Matthew Snape, Professor of Paediatrics and Vaccinology at the Oxford Vaccine Group (OVG) before\u00a0moving to\u00a0Moderna\u00a0in August 2022,\u00a0has been appointed Member of the Most Excellent Order of the British Empire (MBE) for services to Public Health, particularly during COVID-19 while working at the\u00a0OVG.
Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of \u00a37,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.
Experts have launched a new campaign in a bid to boost waning vaccine uptake by giving people more information about how clinical trials work. Researchers hope to alleviate hesitancy by showing with a simple animation and comic the complex way vaccines are developed.
The Chancellor's Autumn statement announced government support for the Rare Therapies Launch Pad, a new programme within the Department of Paediatrics designed to develop regulatory pathways for children with rare conditions to access individualised therapies.
Daniela Ferreira, Professor of Respiratory Infection and Vaccinology at the University of Oxford\u2019s Department of Paediatrics and the Department of Clinical Sciences at the Liverpool School of Tropical Medicine has been awarded one of six prestigious Research Professorships by the National Institute of Health and Care Research (NIHR).
Rebeccah Slater, Professor of Paediatric Neuroscience, Senior Wellcome Fellow and Chair of the Department of Paediatrics\u2019 Equality, Diversity and Inclusivity Committee, has been presented with the Excellent Supervisor Award by the Head of the Medical Sciences Division (MSD).
Experts linked to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford\u2019s vaccine laboratories this week as part of a two-day gathering on accelerating pandemic preparedness.
The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) today announced the launch of a new project to initiate early development of prototype vaccines against the Jun\u00edn virus, selected as an exemplar of the Arenavirus family which is responsible for multiple deadly haemorrhagic fevers with epidemic and pandemic potential.
A pioneering study into human immunity is being launched today by Oxford Vaccine Group at the University of Oxford. The study, called LEGACY03, is being funded by the Medical Research Council part of UK Research and Innovation. By investigating how lymph nodes work, and how they make responses to vaccines in younger and older people, it has the potential to improve vaccine design for different age groups significantly.
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.
The University of Oxford\u2019s commitment to tackling major global health challenges has been strengthened following the endowment of a chair in global health and clinical development. The new permanent post was made possible by a \u00a35 million donation from Brazilian healthcare organisation SAIL for Health.
Researchers at the University of Oxford's Pandemic Sciences Institute have launched a new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS).
The Department of Paediatrics at the University of Oxford is delighted to announce that Anindita Roy has been named Professor of Paediatric Haematology at the University of Oxford.
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to human volunteers for the first time. The clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.
The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
Scientists at the University of Oxford are running a study at participating hospitals in the Thames Valley and Wessex regions, offering parents the ability to have their newborn baby\u2019s blood tested for Spinal Muscular Atrophy (SMA), in addition to the nine other conditions that are already tested for.
Dr Parvinder Aley, Director of Global Operations at the Oxford Vaccine Group, has been recognised and celebrated in the 2023 King\u2019s Birthday Honours list. Dr Aley has been appointed an Officer of the Order of the British Empire (OBE) for services to vaccination during the COVID-19 pandemic.
Simon Marchant, a DPhil student at the Paediatric Neuroimaging Group [https://neuroimaging.paediatrics.ox.ac.uk/], has been awarded the Postgraduate Research Award by the Institute of Engineering and Technology. The award, worth \u00a32,500, was given in recognition of his outstanding engineering research in the field of paediatric neuroimaging.
Professor Irene Roberts, an Emeritus Professor of Paediatric Haematology at the University of Oxford, has this month been awarded the Jean Bernard Lifetime Achievement Award by the European Haematology Association.
![\"\"](\"https://www.paediatrics.ox.ac.uk/news/first-in-human-vaccine-trial-for-nipah-virus/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n